Histone modification enzymes: novel targets for cancer drugs
R Kristeleit, L Stimson, P Workman, W Aherne - Expert Opinion on Emerging Drugs, 2004 - dx.doi.org
... PR HDAC3 428 Shuttling * Ubiquitous NCoR, SMRT, BCoR Rb, HDAC 4, 5, 7,
9, 10, NF-κB, GATA2, YY1 HDAC8 377 Nucleus Ubiquitous II ...
Web Search - extenza-eps.com - ashley-pub.com - ingentaconnect.com - all 8 versions »